BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35822381)

  • 1. [Risk factors of skip lateral cervical lymph node metastasis in papillary thyroid carcinoma].
    Gao J; Xin Y; Yang L; Liu Y; Tian Z; Shang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jul; 36(7):528-532;539. PubMed ID: 35822381
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
    Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
    World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice.
    Nie X; Tan Z; Ge M
    BMC Cancer; 2017 Oct; 17(1):702. PubMed ID: 29070029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.
    Hou J; Zhang Y; Fan Y; Wu B
    Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):493-498. PubMed ID: 32607832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTC located in the upper pole is more prone to lateral lymph node metastasis and skip metastasis.
    Dou Y; Hu D; Chen Y; Xiong W; Xiao Q; Su X
    World J Surg Oncol; 2020 Jul; 18(1):188. PubMed ID: 32723382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma.
    Lei J; Zhong J; Jiang K; Li Z; Gong R; Zhu J
    Oncotarget; 2017 Apr; 8(16):27022-27033. PubMed ID: 28223546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
    Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
    Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
    Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
    Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
    Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
    BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.
    Lee YS; Shin SC; Lim YS; Lee JC; Wang SG; Son SM; Kim IJ; Lee BJ
    Head Neck; 2014 Jun; 36(6):887-91. PubMed ID: 23733708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
    Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
    Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Related factors on skip metastasis of neck lymph node in papillary thyroid carcinoma].
    Zhan X; Xue S; Yin Y; Chen G
    Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):599-602. PubMed ID: 28789510
    [No Abstract]   [Full Text] [Related]  

  • 14. Lateral lymph node metastasis in papillary thyroid carcinoma: results of therapeutic lymph node dissection.
    Chung YS; Kim JY; Bae JS; Song BJ; Kim JS; Jeon HM; Jeong SS; Kim EK; Park WC
    Thyroid; 2009 Mar; 19(3):241-6. PubMed ID: 19265495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of lymph node jump metastasis in papillary thyroid carcinoma].
    Qiao L; Dong C; Zhang N; Ma BL
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 32(7):522-526. PubMed ID: 29798083
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.
    Liu WQ; Yang JY; Wang XH; Cai W; Li F
    BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of lymph node metastasis in level IIB and contralateral level VI for papillary thyroid carcinoma with pN1b and safety of low collar extended incision for neck dissection in level II.
    Ning Y; Liu Y; Zeng D; Zhou Y; Ma L; Dong S; Sheng J; Wu G; Tian W; Cai Y; Li C
    World J Surg Oncol; 2023 Aug; 21(1):249. PubMed ID: 37592337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Delphain lymph node detection rate, metastasis rate and risk factors for metastasis in papillary thyroid adenocarcinoma patients].
    Xin Y; Sun X; Shang X; Xu G; Liu Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Feb; 38(2):150-154;159. PubMed ID: 38297870
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of the relationship between ultrasonographic features and cervical lymph node skip metastasis of papillary thyroid micro-carcinoma].
    Wang XQ; Wei X; Xu Y; Wang HL; Xin XJ; Zhang S
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):373-377. PubMed ID: 31137172
    [No Abstract]   [Full Text] [Related]  

  • 20. Which is preferred for initial treatment of papillary thyroid cancer, total thyroidectomy or lobotomy?
    Wu Z; Han L; Li W; Wang W; Chen L; Yao Y; Wang Y
    Cancer Med; 2021 Mar; 10(5):1614-1622. PubMed ID: 33512778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.